Skip to main content

Regeneron CEO says the next big thing for biotech isn't AI, it's gene therapy

Regeneron CEO Leonard Schleifer detailed the biotech company's newest ventures in the pharmaceutical industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.